Posted 24th December 2018 by Jane Williams
2018 has been another big year for the microbiome and probiotics. Investment is at an all-time high with the global probiotics market expected to grow with a compound annual growth rate of 6.5% over the forecast period of 2018-2024, while the microbiome market is predicted to grow from $235.8 million in 2018 to $521.23 million by 2022. 
Posted 22nd October 2018 by Jane Williams
The Probiotics/Prebiotics Market
Interest in microbiota, specifically in human health and disease, has encouraged consumers to focus on digestive health, which has seen the probiotics and prebiotics market go from strength-to-strength.
As a result, the global probiotics and prebiotics market was valued at approximately USD 40.09 billion in 2017 and is expected to generate revenue of around USD 65.87 billion by end of 2024, growing at a compound annual growth rate of around 7.35% between 2018 and 2024. 
Posted 27th June 2018 by Jane Williams
The microbiome market has gone from strength-to-strength and is expected to grow from $289.411 million to $635.829 million by 2022. The major factors responsible for market growth include:
- Increased risk of gut, autoimmune, inflammatory bowel, and skin health diseases
- Lifestyle changes (eg. diet)
- Ageing population
Posted 30th May 2018 by Jane Williams
The global qPCR & dPCR instrumentation market is growing and is expected to reach 1631.09 million USD by the end of 2025.
Posted 25th April 2018 by Jane Williams
The microfluidic-based devices market has been growing since 2014 due to the increasing point of care testing demand and the miniaturisation of microfluidic chips.
Posted 13th April 2018 by Jane Williams
2017 was a big year for the AgTech industry, with a record $10.1 billion in investments and an increase of 29% from 2016. Looking forward, we decided to put together a list of 119 top AgTech start-ups and investors.
In this article, we’ll be talking through the results that were gathered from the report, which you can view here.
Whether you’re looking for an investor from seed to series or you’re just interested in the market, you are sure to find this resource useful.
Posted 15th February 2018 by Jane Williams
With 2017 now in the rear-mirror, it is a good time to assess the investment landscape in the microbiome space and try to identify relevant trends indicative of where microbiome science and the industry might be headed next. To do this I contacted Matt Martin, Microbiome Innovation and Ventures Lead at the University of Chicago. Matt has been analyzing the space for some time now, and in collaboration with Michael Lohmeier, a student at the Tepper School of Business, Carnegie Mellon University, has kept a tab on companies and investors alike.
Posted 4th October 2017 by Jane Williams
Interest in microbiota has reached all areas of human health and disease. As a result, the therapeutic potential of probiotics has expanded. 2013 saw a surge of investment into prebiotics and probiotics, coinciding with an increase in microbiome funding. In the last decade, investment has quadrupled.